Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

The point-of-care network with the BCMA-directed CART ARI0002h (Cesnicabtagene Autoleucel) in patients with relapsed/refractory multiple myeloma maintains efficacy and safety in real-world data

Blood (2025) 146 (Supplement 1): 135.

https://doi.org/10.1182/blood-2025-135

Published: 2025

Journal Articles

Number of cardiac deaths associated with ibrutinib versus zanubrutinib for the treatment of chronic lymphocytic leukemia: A European risk-based estimation

Talha Munir, Paolo Sportoletti, Andrea Visentin, Leyla Mohseninejad, Lianne Barnieh, Keri Yang, Wassim Aldairy, Sheila Mpima, Vicky Casey, Rhys Williams, Raul Diez Fernandez, Francisco Javier Diaz Galvez, Vincent Levy

Blood (2025) 146 (Supplement 1): 8033.

https://doi.org/10.1182/blood-2025-8033

Published: 2025

Journal Articles

Prognostic variables associated with the development of cytokine release syndrome after bispecific antibodies in non-Hodgkin lymphoma patients – the geltamo (Spanish Lymphoma Group) experience

Angel Serna, Gloria Iacoboni, Anna Aguilera Romero, Victor Navarro, Carolina Martinez, Pablo Manresa, Laura Magnano, Ana Jiménez Ubieto, Sofía Vázquez-Díaz, Maria Jose Rodriguez Salazar, Maria Teresa Busnego Barreto, Raquel Del Campo, Pedro José Paúl Vidaller, Ilda Murillo, Eva Donato, Hugo Daniel Luzardo Henríquez, Pilar Gomez Prieto, Elena Perez Ceballos, Begona Mendibil, Sergio Ramos, Ana Maria Garcia-Noblejas Moya, Sonia González De Villambrosia, Francisco Javier Diaz Galvez, Javier Lopez Jimenez, Paula Fernández-Caldas, Ruben Fernandez Alvarez, Antonio Gutierrez, Blanca Sanchez, Nazaret Dominguez, María Civeira Marin, Paola Villafuerte Gutiérrez, Iñigo Olazabal, Izaskun Zeberio, Cristina Barrenetxea Lekue, Diego Clavo-Martín, Samuel Romero Dominguez, Sofia Martin-Consuegra, Sofia Huerga, Nuria Golbano, Rosalia Riazza, Jose Antonio Hueso García, Pilar Martinez-Barranco, Belen Navarro Matilla, Lucia Villalon Blanco, Paula Ortega Nadal, Ana Torres Tienza, Alejandro Martin Garcia-Sancho, Mariana Bastos-Oreiro, Pau Abrisqueta

Blood (2025) 146 (Supplement 1): 3737.

https://doi.org/10.1182/blood-2025-3737

Published: 2025

Journal Articles

Toxicity, efficacy, and clinical management of bispecific antibodies in routine clinical practice: A real-world geltamo study in B-cell lymphoma

Mariana Bastos-Oreiro, Gloria Iacoboni, Pablo Manresa, Carolina Martinez, Laura Magnano, Ana Jiménez Ubieto, Sofía Vázquez-Díaz, Maria Jose Rodriguez Salazar, Maria Teresa Busnego Barreto, Raquel Del Campo, Pedro José Paúl Vidaller, Ilda Murillo, Eva Donato, Angel Serna, Hugo Daniel Luzardo Henríquez, Pilar Gomez Prieto, Elena Perez Ceballos, Begona Mendibil, Sergio Ramons, Ana Maria Garcia-Noblejas Moya, Sonia González De Villambrosia, Francisco Javier Diaz Galvez, Javier Lopez Jimenez, Paula Fernandez-Caldas, Antonio Gutierrez, Blanca Sanchez, Nazaret Dominguez, María Civeira Marin, Paola Villafuerte Gutiérrez, Izaskun Zeberio, Irati Ormezabal, Cristina Barrenetxea Lekue, Norma Gutiérrez, Sofia Martin-Consuegra, Samuel Romero Dominguez, Sofia Huerga, Nuria Golbano, Rosalia Riazza, Jose Antonio Hueso García, Pilar Martinez-Barranco, Belen Navarro Matilla, Lucia Villalon Blanco, Paula Ortega Nadal, Ana Torres Tienza, Víctor Navarro Garces, Pau Abrisqueta, Alejandro Martin Garcia-Sancho

Blood (2025) 146 (Supplement 1): 2732.

https://doi.org/10.1182/blood-2025-2732

Published: 2025

Journal Articles

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

Francisco Javier Gil Etayo, Rodrigo Gil-Manso, JAIRO EDUARDO NIÑO RAMÍREZ, Marta Fonseca-Santos, JUAN LÓPEZ-PÉREZ, ISABEL JIMÉNEZ HERNAZ, ARIADNA VICENTE PARRA, PILAR TERRADILLOS SÁNCHEZ, NURIA CALZADA, DANIEL ARROYO-SÁNCHEZ, FRANCISCO BOIX, Almudena Navarro-Bailón, SARA MARCOS ASENSIO, Estefanía Pérez López, Ramon Garcia-Sanz, Fermin Sanchez-Guijo, Lucia Lopez Corral, AMALIA TEJEDA VELARDE

Blood (2025) 146 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2025-4296

Published: 2025

Journal Articles

Beyond remission: Sexual health and quality of life in survivors of acute leukemia

Lyam Carlo Chacon Rangel, Rosa Elena Aguilar-Fuentes, Ivan Arnaud-Borboa, Itzel Jocelyn Lopez-Hernandez, Frida Rodriguez Contreras, Fausto Rios-Olais, Manuel Alejandro Cruz Martínez, Veronica Steffania Corral Herrera, Francisco Javier Merayo-Chalico, Juan Ontiveros-Austria, Maria Roberta Demichelis Gomez

Blood (2025) 146 (Supplement 1): 2749.

https://doi.org/10.1182/blood-2025-2749

Published: 2025

Journal Articles

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Blood (2025) 146 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2025-2471

Published: 2025

Journal Articles

Real-world experience with hematopoietic stem cell transplantation in acute leukemias: Clinical landscape and impact of early cyclosporine a exposure on post-transplant complications and outcomes

Oscar Jaime Moreno-García, Amaya Llorente-Chávez, Kenya Esmeralda Mendoza-Salguero, Rodrigo Figueroa-Méndez, Diego Sierra-Ulloa, Francisco Javier Gutiérrez-Ramírez, Irma Pellon Tellez, Luis Manuel Valero-Saldaña

Blood (2025) 146 (Supplement 1): 7749.

https://doi.org/10.1182/blood-2025-7749

Published: 2025

Journal Articles

Venetoclax in combination with hypomethylating agents in adult patients with newly diagnosed AML with CBFB::MYH11 or RUNX1::RUNX1T1 fusions: Real-world outcomes based on international registry data

Blood (2025) 146 (Supplement 1): 5230.

https://doi.org/10.1182/blood-2025-5230

Published: 2025

Journal Articles

Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331

Ramon Garcia-Sanz, Anna Sureda Balari, Eva Domingo Domenech, Francisco Javier Capote Huelva, Antonio Gutierrez, Antonia Rodriguez Izquierdo, Marta Grande De Domingo, Lourdes Baeza

Blood (2024) 144 (Supplement 1): 2376.

https://doi.org/10.1182/blood-2024-193585

Published: 2024

Journal Articles

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Antonio Gutiérrez, Izaskun Zeberio, Pilar Martinez-Barranco, Francisco Javier Peñalver, Sandra Pérez, Daniel Morillo, Xabier Mart N Martitegui, Concepción Nicolás, Ainara Ferrero, Ana Jiménez Ubieto, Mariana Bastos-Oreiro, Julio Dávila-Valls, Maria Victoria Calle Gordo, María Pérez Sala, Guillermo Rodríguez Garcia, Aranzazu Alonso Alonso, Ana Garcia Noblejas, Diana Sanchez Arguello, Teresa Knight Asorey, Maria Angeles Fernandez Fernandez, Javier López Marin, Jaime Perez de Oteyza, Sonia González De Villambrosia, Elena Perez Ceballos, Alejandro Marin, Belén Navarro, Ruben Fernandez Alvarez, Pilar Gómez, Jose Antonio Hueso, Maria Jesus Penarrubia Ponce, Pilar Bravo, Daniel García Belmonte, Haridian De La Nuez Melian, Sara Nistal, Pau Abrisqueta Costa, Fernanda Ibañez, Luis Palomera, Eva Donato, Andrea Provencio Rincon, Maria Stefania Infante, Eva Gonzalez Barca

Blood (2024) 144 (Supplement 1): 2356.

https://doi.org/10.1182/blood-2024-210868

Published: 2024

Journal Articles

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Michelle Morcos, Alexia Gonzalez, Héctor Alejandro Vaquera Alfaro, Dalila Marisol Alvarado-Navarro, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Rosario Salazar-Riojas, Maria Luisa Aguilar-Escobedo, Luis Paulo Ugarte Pelaez, Francisco Javier Rubio Macias, Olga Cantu, David Gomez-Almaguer, Nidia Karina Moncada Saucedo

Blood (2024) 144 (Supplement 1): 7514.

https://doi.org/10.1182/blood-2024-208823

Published: 2024

Journal Articles

Home Care in Oncohematological Patients Not Candidates for Intensive Chemotherapy: From Active Treatment to the End of Life. Ambispective Multicentric Study on Dual and Early Assessment of Palliative Care and Hematology in a Rural Environment

Bolivar Diaz Jordan, Marta Torcal Baz, Claudia Corona Lopez, Francisco Javier Gomez Romero, Ana Rosa Lopez Quiñones Pimentel, Maria Isabel Goyanes Martin, Rosario Melero Cañadas, Raquel Jimenez Megia, Almudena Valverde Templado, Ana Belen Friginal Ruiz, Claudia Maria Rodriguez Gomez, Teresa Cañizares Fernandez, Gema Garrandes Gallego, Maria Eugenia Carrillo Coca, Martin A. Cabero-Becerra

Blood (2024) 144 (Supplement 1): 2270.

https://doi.org/10.1182/blood-2024-198818

Published: 2024

Journal Articles

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Tomás José González-López, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, Josefa Luis-Navarro, Sunil Lakhwani, Natalia Acedo, María Luisa Lozano, Silvia Bernat, Ana Torres-Tienza, Ana Ruano, Isidro Jarque, Pilar Galán, Carmen Benet, Shally Marcellini, Reyes Jimenez-Bárcenas, Daniel Martínez-Carballeira, Dunia De Miguel-Llorente, Alvaro Perona-Blázquez, Isabel Gonzalez-Gascón, Elsa Lopez-Ansoar, José María Alonso-Alonso, María Luisa Bengochea-Casado, Francisco Javier Díaz-Gálvez, Ana Moretó, Gemma Moreno-Jiménez, Roberto Hernández-Martin, Erik de Cabo, Julio Dávila-Valls, Amalia Cuesta, Carmen Pastoriza, Gerardo Julio Hermida-Fernández, Covadonga García, Miguel Angel Pozas-Mañas, Carlos Aguilar, Dolores Fernandez-Jimenez, Begoña Navas-Elorza, Carolina López-Santamaría Castro, Alvaro Lorenzo, Xavier Ortín, Marta García, Sonia Piernas, Johana Díaz-Santa, Inmaculada Soto, Drew Provan, Gloria García-Donas Gabaldón

Blood (2024) 144 (6): 646–656.

https://doi.org/10.1182/blood.2024024250

Published: 2024

Journal Articles

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

Blood (2023) 142 (Supplement 1): 2591.

https://doi.org/10.1182/blood-2023-190511

Published: 2023

Journal Articles

Impact of the Mexican Healthcare Reform on Optimal Treatment Delivery, Survival, and Response Rates Among a Cohort of Patients with Diffuse Large B Cell Lymphoma in a Single National Reference Institution

Francisco Javier Gutiérrez Ramírez, Alejandro Aviles, Francisco Osvaldo García-Pérez, Valentin Lozano, Myrna Candelaria

Blood (2023) 142 (Supplement 1): 7402.

https://doi.org/10.1182/blood-2023-189436

Published: 2023

Journal Articles

Comprehensive Geriatric Assessment and Geriatric Intervention in Older Patients with Newly Diagnosed Lymphoma: A Prospective Study

Alberto Lopez Garcia, Ana Isabel Hormigo, Ignacio Mahillo, Elham Askari, Daniel Morillo, Maria Angeles Perez Saez, Elena Prieto, Miriam Riesco, Celia Urrutia, Francisco Javier Martinez Peromingo, Juan Ignacio Gonzalez Montalvo, Raul Cordoba

Blood (2023) 142 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2023-181652

Published: 2023

Journal Articles

Structural Effect of G γ and A γ Globin Chains in Fetal Hemoglobin Tetramer

Francisco Javier Borrayo López, Izchel Figarola Centurion, Francisco Javier Perea Díaz, César Millán Pacheco, Bertha Ibarra Cortés, Blanca Miriam Torres Mendoza, Juan Antonio Flores-Jimenez, Lourdes Del Carmen Rizo-De La Torre

Blood (2023) 142 (Supplement 1): 2291.

https://doi.org/10.1182/blood-2023-188988

Published: 2023

Journal Articles

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

Blood (2023) 142 (Supplement 1): 4511.

https://doi.org/10.1182/blood-2023-186952

Published: 2023

Journal Articles

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Blood (2023) 141 (3): 309–314.

https://doi.org/10.1182/blood.2022017439

Published: 2023

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The point-of-care network with the BCMA-directed CART ARI0002h (Cesnicabtagene Autoleucel) in patients with relapsed/refractory multiple myeloma maintains efficacy and safety in real-world data

Number of cardiac deaths associated with ibrutinib versus zanubrutinib for the treatment of chronic lymphocytic leukemia: A European risk-based estimation

Prognostic variables associated with the development of cytokine release syndrome after bispecific antibodies in non-Hodgkin lymphoma patients – the geltamo (Spanish Lymphoma Group) experience

Toxicity, efficacy, and clinical management of bispecific antibodies in routine clinical practice: A real-world geltamo study in B-cell lymphoma

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

Beyond remission: Sexual health and quality of life in survivors of acute leukemia

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Real-world experience with hematopoietic stem cell transplantation in acute leukemias: Clinical landscape and impact of early cyclosporine a exposure on post-transplant complications and outcomes

Venetoclax in combination with hypomethylating agents in adult patients with newly diagnosed AML with CBFB::MYH11 or RUNX1::RUNX1T1 fusions: Real-world outcomes based on international registry data

Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Home Care in Oncohematological Patients Not Candidates for Intensive Chemotherapy: From Active Treatment to the End of Life. Ambispective Multicentric Study on Dual and Early Assessment of Palliative Care and Hematology in a Rural Environment

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry

Impact of the Mexican Healthcare Reform on Optimal Treatment Delivery, Survival, and Response Rates Among a Cohort of Patients with Diffuse Large B Cell Lymphoma in a Single National Reference Institution

Comprehensive Geriatric Assessment and Geriatric Intervention in Older Patients with Newly Diagnosed Lymphoma: A Prospective Study

Structural Effect of G γ and A γ Globin Chains in Fetal Hemoglobin Tetramer

Early Identification of Very High Risk Patients with Diffuse Large B Cell Lymphoma (DLBCL) By PET-CT

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only